Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Baxter
Boehringer Ingelheim
Mallinckrodt
AstraZeneca

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076103


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 076103 describes IPRATROPIUM BROMIDE, which is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb Inc, Landela Pharm, Mylan Speciality Lp, Nephron, Pharmascience Inc, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Bausch And Lomb, and Hikma, and is included in twenty-one NDAs. It is available from fourteen suppliers. Additional details are available on the IPRATROPIUM BROMIDE profile page.

The generic ingredient in IPRATROPIUM BROMIDE is ipratropium bromide. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.
Summary for 076103
Tradename:IPRATROPIUM BROMIDE
Applicant:Bausch And Lomb
Ingredient:ipratropium bromide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076103
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for 076103
Suppliers and Packaging for NDA: 076103
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076103 ANDA Bausch & Lomb Incorporated 24208-399 24208-399-15 1 BOTTLE, SPRAY in 1 CARTON (24208-399-15) > 165 SPRAY, METERED in 1 BOTTLE, SPRAY

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrength0.042MG/SPRAY
Approval Date:Mar 31, 2003TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Colorcon
Medtronic
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.